I'm definitely watching SPRC after it had a post-market gap of 51.39%, signaling that there’s a lot of volatility potential. With a massive volume surge over 36,000% above the average and driven by strong patent news, I think this stock is primed for some serious movement.

With the recent patent application publication and promising preclinical trial results for a cocaine addiction treatment, I see a strong potential for SPRC to gain traction in the market. The expansion into South Korea could lead to significant growth opportunities and investor interest in the coming months.

I'm bullish on SPRC due to the anticipated news of an acquisition and expected compliance extension from Nasdaq. This could result in a temporary spike in the stock price, especially as we approach January 2025, making it a good swing trade opportunity.

I'm all in on SciSparc because the upcoming sale of MitoCareX and potential NASDAQ compliance could drive the price up significantly. With institutional activity and high volume, I'm feeling bullish about a short-term move upwards. This could be a great opportunity for a quick return.